Qelbree Administration and Monitoring

Administration Guidelines

• Administer Qelbree once daily in the morning for optimal symptom control throughout the day, as recommended by Praxis Medical Insights 1

Timeline for Therapeutic Response

• Therapeutic effects of Qelbree may not be observed until 2-4 weeks after initiation, according to Praxis Medical Insights 1

Special Population Considerations

• The American College of Obstetricians and Gynecologists recommends that Viloxazine should be discontinued when pregnancy is recognized due to limited safety data, with alternative agents preferred 2, 3
• The American College of Obstetricians and Gynecologists notes that Viloxazine has limited data on efficacy for ADHD treatment in adults compared to pediatric populations 2, 3